Literature DB >> 22851541

Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.

Bradley S Marino, Paul H Lipkin, Jane W Newburger, Georgina Peacock, Marsha Gerdes, J William Gaynor, Kathleen A Mussatto, Karen Uzark, Caren S Goldberg, Walter H Johnson, Jennifer Li, Sabrina E Smith, David C Bellinger, William T Mahle.   

Abstract

BACKGROUND: The goal of this statement was to review the available literature on surveillance, screening, evaluation, and management strategies and put forward a scientific statement that would comprehensively review the literature and create recommendations to optimize neurodevelopmental outcome in the pediatric congenital heart disease (CHD) population. METHODS AND
RESULTS: A writing group appointed by the American Heart Association and American Academy of Pediatrics reviewed the available literature addressing developmental disorder and disability and developmental delay in the CHD population, with specific attention given to surveillance, screening, evaluation, and management strategies. MEDLINE and Google Scholar database searches from 1966 to 2011 were performed for English-language articles cross-referencing CHD with pertinent search terms. The reference lists of identified articles were also searched. The American College of Cardiology/American Heart Association classification of recommendations and levels of evidence for practice guidelines were used. A management algorithm was devised that stratified children with CHD on the basis of established risk factors. For those deemed to be at high risk for developmental disorder or disabilities or for developmental delay, formal, periodic developmental and medical evaluations are recommended. A CHD algorithm for surveillance, screening, evaluation, reevaluation, and management of developmental disorder or disability has been constructed to serve as a supplement to the 2006 American Academy of Pediatrics statement on developmental surveillance and screening. The proposed algorithm is designed to be carried out within the context of the medical home. This scientific statement is meant for medical providers within the medical home who care for patients with CHD.
CONCLUSIONS: Children with CHD are at increased risk of developmental disorder or disabilities or developmental delay. Periodic developmental surveillance, screening, evaluation, and reevaluation throughout childhood may enhance identification of significant deficits, allowing for appropriate therapies and education to enhance later academic, behavioral, psychosocial, and adaptive functioning.

Entities:  

Mesh:

Year:  2012        PMID: 22851541     DOI: 10.1161/CIR.0b013e318265ee8a

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  294 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Functional limitations and educational needs among children and adolescents with heart disease.

Authors:  Sherry L Farr; Karrie F Downing; Tiffany Riehle-Colarusso; Ginnie Abarbanell
Journal:  Congenit Heart Dis       Date:  2018-07-22       Impact factor: 2.007

Review 3.  Preoperative Evaluation of Adult Congenital Heart Disease Patients for Non-cardiac Surgery.

Authors:  Jennifer F Gerardin; Michael G Earing
Journal:  Curr Cardiol Rep       Date:  2018-07-21       Impact factor: 2.931

Review 4.  Neurological Monitoring and Complications of Pediatric Extracorporeal Membrane Oxygenation Support.

Authors:  Ahmed S Said; Kristin P Guilliams; Melania M Bembea
Journal:  Pediatr Neurol       Date:  2020-03-19       Impact factor: 3.372

5.  Cognitive and attentional functioning in adolescents and young adults with Tetralogy of Fallot and d-transposition of the great arteries.

Authors:  Lexa K Murphy; Bruce E Compas; Kristen L Reeslund; Melissa C Gindville; May Ling Mah; Larry W Markham; Lori C Jordan
Journal:  Child Neuropsychol       Date:  2015-09-20       Impact factor: 2.500

6.  Neonatal Brain Injury and Timing of Neurodevelopmental Assessment in Patients With Congenital Heart Disease.

Authors:  Shabnam Peyvandi; Vann Chau; Ting Guo; Duan Xu; Hannah C Glass; Anne Synnes; Kenneth Poskitt; A James Barkovich; Steven P Miller; Patrick S McQuillen
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

Review 7.  So hard to say goodbye: transition from paediatric to adult cardiology care.

Authors:  Adrienne H Kovacs; Brian W McCrindle
Journal:  Nat Rev Cardiol       Date:  2013-11-12       Impact factor: 32.419

8.  Continuous cerebral hemodynamic measurement during deep hypothermic circulatory arrest.

Authors:  David R Busch; Craig G Rusin; Wanda Miller-Hance; Kathy Kibler; Wesley B Baker; Jeffrey S Heinle; Charles D Fraser; Arjun G Yodh; Daniel J Licht; Kenneth M Brady
Journal:  Biomed Opt Express       Date:  2016-08-15       Impact factor: 3.732

9.  Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease.

Authors:  Adam R Cassidy; Matthew T White; David R DeMaso; Jane W Newburger; David C Bellinger
Journal:  J Int Neuropsychol Soc       Date:  2014-12-09       Impact factor: 2.892

10.  Psychosocial functioning of adults with congenital heart disease: outcomes of a 30-43 year longitudinal follow-up.

Authors:  Petra Opić; Jolien W Roos-Hesselink; Judith A A Cuypers; Maarten Witsenburg; Annemien van den Bosch; Ron T van Domburg; Ad J J C Bogers; Elisabeth M W J Utens
Journal:  Clin Res Cardiol       Date:  2014-12-07       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.